SUBSCRIBE
SUBSCRIBE

GSK Bio

NEWS
Business
GlaxoSmithKline’s CEO Emma Walmsley Tries to Conquer Old R&D Demons
August 7, 2017
 · 
1 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
GlaxoSmithKline to Shift Neuro R&D Out of China to Philadelphia Research Hub
August 4, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
United Therapeutics Shares Surge on Report of Bids for Company
August 4, 2017
 · 
2 min read
AstraZeneca PLC Offloads Remaining Anesthetics Portfolio in $766 Million Deal
Deals
AstraZeneca PLC Seen as “Tricky” Takeover Target After Big Setback Last Week
August 1, 2017
 · 
3 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25%
July 28, 2017
 · 
3 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Some GlaxoSmithKline Critics Would Prefer Walmsley Broke Up the Company
July 28, 2017
 · 
3 min read
Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Drug Development
Death Count Rises for Patients on Dynavax’s Hep B Vaccine But Overall Rate Was Low, Says the FDA
July 26, 2017
 · 
2 min read
GlaxoSmithKline CEO Kills 30+ Pre-Clinical and Clinical Programs
GlaxoSmithKline CEO Kills 30+ Pre-Clinical and Clinical Programs
July 26, 2017
 · 
3 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Brace Yourself: GlaxoSmithKline’s New CEO Gets Ready to Overhaul the Drug Pipeline
July 24, 2017
 · 
3 min read
Load More
  • 2026 - Best Places to Work - Badge (1).png
JOBS
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
 · 
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
 · 
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
 · 
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
 · 
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
 · 
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
 · 
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
 · 
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
 · 
5 min read